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1. Introduction 
The cytochrome P-450~linked mono-oxygenase 
system which resides in the liver microsomes and also 
in other tissues metabolizes a vast number of foreign 
as well as endogenous compounds, including drugs, 
steroids, pesticides etc. [ 11. The pre-requisite for the 
metabolism is supposed to be a binding of substrate 
to oxidized cytochrome P-450 which is often observ- 
able in the difference spectrum of the microsomes as 
a type I spectral change, characterized by a trough 
at about 420 nm and a peak at about 390 nm [2,3]. 
Because the cytochrome P-450~linked mono- 
oxygenase system of liver microsomes is very un- 
specific with respect to metabolizable substrates 
there have been attempts to find common properties 
for the heterogeneous group of cytochrome P-450 
substrates. Gaudette and Brodie [4] were first to 
point out that there appears to be a direct relation- 
ship between the rate of microsomal metabolism and 
the lipophilic character of drugs. Later, McMahon [5] 
and Martin and Hansch [6] found rough correlations 
between lipid solubility and metabolism by the cy- 
tochrome P-450 system for various groups of com- 
pounds. On the other hand, other studies that although 
lipid solubility may be required for a substance to be 
metabolized by, and to interact with microsomal 
cytochrome P-450, other properties of the molecule, 
e.g. stereoselectivity, are of major importance for 
determining the affinity with which it will interact 
with the cytochrome [7-91. 
In the present study, a series of chlorinated hydro- 
carbons, methanes, ethanes, ethanes have been studied 
with respect to spectral interactions with cytochrome 
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P-450 of liver microsomes from control, phenobarbital- 
treated, and 3-methyl-cholanthrene-treated rats. We 
found that the addition of these compounds resulted 
in type I spectral interactions. The systematic change 
in the molecule (the increasing number of chlorine 
atoms) resulted in a systematic change in the bio- 
chemical parameter (the increased magnitude of the 
type I spectral change and the increased affinity to 
cytochrome P-450). Because the successive addition 
of chlorine atoms to the hydrocarbon skeleton leads 
to the increase in hydrophobicity or lipid solubility 
of the compound [lo] we conclude that the important 
property of the molecule for deciding the affinity 
to cytochrome P-450 is lipid solubility, at least in 
this series of chlorinated hydrocarbons. 
2. Materials and methods 
Male rats of Sprague-Dawley strain weighing 250 
to 300 g were used. Animals were treated by pheno- 
barbital (500 mg/l in drinking water for 7 days) or 
3-methylcholanthrene (20 mg/kg body weight for 
three days i.p. in sesame oil). Animals were killed 
24 hr after stopping the treatment. The liver was 
immediately removed, washed, and homogenized in 
4 vol of 0.1 M K/Na phosphate buffer, pH 7.4, by 
a glass-teflon homogenizer. After centrifugation of 
homogenate at 10 000 g for 20 min, the microsomal 
fraction was obtained by centrifugation at 100 000 g 
for 60 min. The microsomal pellet was suspended in 
0.1 M Tris-HCl, pH 7.45, at a protein concentration 
of about 20 to 30 mg per ml. protein concentrations 
were determined by the Biuret method [ 111. 
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For determination of spectral interactions, the s 
microsomal suspension was diluted with Tris-HCl 
Y 
d 
to yield a protein concentration of about 1 to 4 mg/ml. z 0.05 D 
All spectra were measured at room temperature in 
l-cm path-length cells in a Shimadzu model MPS-SOL 
recording spectrophotometer. Microsomal suspension 
was divided into two cuvettes and the baseline was 
adjusted. Difference spectra were then obtained by 
addition of 1.11 quantities of the compound in acetone 
(vol up to 50 ~1/3 ml) to one of the cuvettes, while 
an equal vol of acetone was added to the reference 
cuvette. Spectra were traced immediately after the 
addition of the substances. The extent of spectral 
changes was measured by the difference between the 
wavelengths of minimum (at 420 nm) and maximum 
(at 385-390 nm) absorption. Spectral dissociation 
constants [3] were obtained from double-reciprocal 
plots of hydrocarbon concentration and spectral 
change. 
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Fig.2. Magnitude of spectral interactions of chlorinated 
hydrocarbons with liver microsomes from control (C), 
phenobarbital-treated (PB), and 3-methylcholanthrene- 
treated (MC) rats. (A - a) methane series; (o - o) 
ethane series; (0 - 0) ethene series. 
The amount of cytochrome P-450 in microsomes 
was measured according to the method of Omura 
and Sato [ 121. 
3. Results 
Fig. 1 and 2 shows that all compounds belonging 
to chlorinated methanes, ethanes, and ethenes except 
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Fig.1. Spectral interactions of 1,1-dichloroethane (l), 1,2- 
di-chloroethane (2), l,l,l-trichloroethane (3), l,l,Ztrichloro- 
ethane (4), 1,1,2,2-tetrachloroethane (5), pentachloroethane 
(6), and hexachloroethane (7) with liver microsomes from 
phenobarbital-treated rats. The final concentrations of the 
compounds were 1 mM (l-5), 0.5 mM (6), and 0.2 mM 
(7). The concentration of cytochrome P-450 was 2.2 nmol/ml. 
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dichloromethane give a type I spectral change with at 
least some rat liver microsomal preparations. Fig. 1 re- 
presents an example of spectral changes after the 
addition of chlorinated ethanes to the microsomal 
suspension from phenobarbital-treated rat liver and 
this experiment gave us the first hint of a systematic 
change of this biochemical parameter and prompted 
us for further studies. 
Fig.2 shows the magnitude of spectral inter- 
actions with liver microsomes from control, pheno- 
barbital-treated, and 3-methylcholanthrene-treated 
rats. Two facts are evident in this figure: the magni- 
tude of the spectral change increases when more 
chlorine atoms are added to the carbon skeleton, 
and the magnitudes of type I spectral changes, when 
calculated on the basis of unit concentration of 
cytochrome P-450, differed much in preparations 
from variously-treated rats. The ‘specific spectral 
changes’ were the largest in the phenobarbital- 
treated group and the smallest in the 3-methyl- 
cholanthrene group. 
Fig.3 shows the double-reciprocal plots for the 
interaction of chlorinated ethanes with liver mic- 
rosomes from phenobarbital-treated rats. It is clear 
that the more chlorine atoms in the molecule, the 
smaller the spectral dissociation constant (KS), 
indicating higher affinity to cytochrome P-450. How- 
ever, with hexachloroethane, pentachloroethane, and 
12 
Volume 5 1, number 1 FEBS LETTERS March 1975 
Fig.3. Double-reciprocal plots of the interaction of hexachloro- 
ethane (l), pentachloroethane (2), 1,1,2,2-tetrachloroethane 
(3), 1,1,2-trichloroethane (4), and l,l,l-trichloroethane (5) 
with the liver microsomal cytochrome P-450 from pheno- 
barbital-treated rats. 
tetrachloroethene, plots are not linear, but apparently 
two-phasic (fig.4). This could be interpreted as if 
in phenobarbital-treated liver microsomes there exist 
two binding sites for chlorinated hydrocarbons with 
differing affinities (‘low’ and ‘high’ affinity binding 
sites). In table 1 KS values for the interaction of some 
chlorinated hydrocarbons with microsomal cytochrome 
Fig.4. Double-reciprocal plots of the interaction of pent- 
achloroethane (c - o) and hexachloroethane (A - a) 
with liver microsomal cytochrome P-450 from pheno- 
barbital-treated rats. 
P-450 are shown. For pentachloroethane, hexachloro- 
ethane, and tetrachloroethene KS values in control 
and 3-methylcholanthrene-treated microsomes were 
roughly similar, but in phenobarbital-treated micro- 
somes they were much smaller. 
4. Discussion 
Since the study of Gaudette and Brodie [4] the 
accepted thought has been that drug oxidation depends 
on the lipid solubility of the compound, thus impli- 
cating that substrate binding sites of drug-oxidizing 
Table 1 
Spectral dissociation constants for the interaction of chlorinated hydrocarbons with 
liver microsomal cytochrome P-450 from variously-treated rats 
Compound 
Spectral dissociation constant (PM) 
Control Phenobarbital-treated 3-methylcholanthrene-treated 
Tetrachloromethane nd’ 500 nd 
l,l,l-trichloroethane nd 1000 nd 
1,1,2-trichloroethane nd 1000 nd 
1,1,2,2-tetrachloroethane nd 250 nd 
F’entachloroethane 179 77 (14)2 185 
Hexachloroethane 77 48 (8) 83 
Tetrachloroethane 278 56 (26) 455 
Values are based on duplicate determinations with microsomes from pooled rat livers, 4 to 6 
rats in each treatment groups. 
’ indicates not determined. 
’ values in parenthesis are KS values of ‘high’ affinity binding site of cytochrome P-450. 
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enzymes are behind the hydrophobic barrier. This 
view has been supported [5,6] , also with respect to 
microsomal conjugations [ 13,141, and challenged 
by later studies [7-91. These two views on the role 
of lipid solubility in drug-microsome interactions 
need not be entirely contradictory, because one can 
imagine that a compound must have minimum lipid 
solubility in order to be metabolizable by the 
microsomal system and if this requirement is ful- 
filled, mainly other properties, e.g. stereoselectivity 
affect the actual interaction of a compound with the 
microsomal cytochrome P-450. 
Since we showed that the inducibility of cytochrome 
P-450~linked drug oxidation is inversely correlated 
with the lipid solubihty of barbiturates (with the 
exception of allyl-barbiturates) [ 151 we have search- 
ed for a suitable series of simple compounds for 
studying the effect of lipid solubility on drug-cyto- 
chrome P-450 interactions. Fujita et al. [lo] have 
shown that the addition of chlorine atoms to the 
carbon skeleton increases lipid solubility of a 
compound. In a series of chlorine-substituted 
methanes, ethanes, and ethenes we showed that the 
more chlorine atoms in the molecule the larger the 
type I spectral change and the smaller the spectral 
dissociation constant. The absolute values of inter- 
action parameters (Ks, O.D.,,) depend on the nature 
of the microsomal preparation. This may indicate 
that different kinds of CO-binding hemoproteins 
reside in the microsomes from variously-treated 
rat livers. It is interesting that the treatment of rats 
with 3-methyl-cholanthrene decreases the magnitude 
of type I spectral changes although it increases the 
amount of microsomal CO-binding hemoprotein. 
Despite differences mentioned above the present 
study seems to support the opinion that an important 
property of a compound to determine its affinity to 
cytochrome P-450 (it is, K,) and its extent of inter- 
action (it is O.D.,,), is lipid solubility. However, 
this fact does not deny the possible significance 
of stereochemical factors in the interaction of more 
complicated compounds with the cytochrome P-450. 
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